About Intellectual Property IP Training Respect for IP IP Outreach IP for… IP and... IP in... Patent & Technology Information Trademark Information Industrial Design Information Geographical Indication Information Plant Variety Information (UPOV) IP Laws, Treaties & Judgements IP Resources IP Reports Patent Protection Trademark Protection Industrial Design Protection Geographical Indication Protection Plant Variety Protection (UPOV) IP Dispute Resolution IP Office Business Solutions Paying for IP Services Negotiation & Decision-Making Development Cooperation Innovation Support Public-Private Partnerships AI Tools & Services The Organization Working with WIPO Accountability Patents Trademarks Industrial Designs Geographical Indications Copyright Trade Secrets WIPO Academy Workshops & Seminars IP Enforcement WIPO ALERT Raising Awareness World IP Day WIPO Magazine Case Studies & Success Stories IP News WIPO Awards Business Universities Indigenous Peoples Judiciaries Genetic Resources, Traditional Knowledge and Traditional Cultural Expressions Economics Gender Equality Global Health Climate Change Competition Policy Sustainable Development Goals Frontier Technologies Mobile Applications Sports Tourism PATENTSCOPE Patent Analytics International Patent Classification ARDI – Research for Innovation ASPI – Specialized Patent Information Global Brand Database Madrid Monitor Article 6ter Express Database Nice Classification Vienna Classification Global Design Database International Designs Bulletin Hague Express Database Locarno Classification Lisbon Express Database Global Brand Database for GIs PLUTO Plant Variety Database GENIE Database WIPO-Administered Treaties WIPO Lex - IP Laws, Treaties & Judgments WIPO Standards IP Statistics WIPO Pearl (Terminology) WIPO Publications Country IP Profiles WIPO Knowledge Center WIPO Technology Trends Global Innovation Index World Intellectual Property Report PCT – The International Patent System ePCT Budapest – The International Microorganism Deposit System Madrid – The International Trademark System eMadrid Article 6ter (armorial bearings, flags, state emblems) Hague – The International Design System eHague Lisbon – The International System of Appellations of Origin and Geographical Indications eLisbon UPOV PRISMA UPOV e-PVP Administration UPOV e-PVP DUS Exchange Mediation Arbitration Expert Determination Domain Name Disputes Centralized Access to Search and Examination (CASE) Digital Access Service (DAS) WIPO Pay Current Account at WIPO WIPO Assemblies Standing Committees Calendar of Meetings WIPO Webcast WIPO Official Documents Development Agenda Technical Assistance IP Training Institutions COVID-19 Support National IP Strategies Policy & Legislative Advice Cooperation Hub Technology and Innovation Support Centers (TISC) Technology Transfer Inventor Assistance Program WIPO GREEN WIPO's Pat-INFORMED Accessible Books Consortium WIPO for Creators WIPO Translate Speech-to-Text Classification Assistant Member States Observers Director General Activities by Unit External Offices Job Vacancies Procurement Results & Budget Financial Reporting Oversight
Arabic English Spanish French Russian Chinese
Laws Treaties Judgments Browse By Jurisdiction

Patents (Amendment) Ordinance 2007 (Ordinance No. 21 of 2007) (Chapter 514), Hong Kong, China

Back

Latest Version in WIPO Lex
Year of Version 2007 Dates Entry into force: February 22, 2008 Issued: November 29, 2007 Type of Text Main IP Laws Subject Matter Patents (Inventions) Notes The notification by Hong Kong to the WTO under article 63.2 of TRIPS states:
'To implement the Protocol Amending the Agreement on Trade-Related Aspects of Intellectual Property Rights of the World Trade Organisation (“WTO”) adopted by the General Council of the WTO at Geneva on 6 December 2005 (“Protocol”) which aim is to facilitate access to patented pharmaceutical products for addressing public health problems.
To enable Hong Kong, China, before the coming into force of the Protocol, to make use of the Decision adopted by the General Council of the WTO on 30 August 2003 on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement an Public Health adopted on 14 November 2001 by the Fourth WTO Ministerial Conference at Doha, Qatar (“GC Decision”) to import or export patented pharmaceutical products from or to any of the WTO Members, regardless of whether such Member is relying on the Protocol or the GVC Decision.
To provide Hong Kong, China with added flexibility when sourcing patented pharmaceutical products to address any public health problem or threatened public health problem during a period of extreme urgency, as in providing the legal framework for the application and issue of import compulsory licenses; and to allow local generic medicine manufacturers to produce and export pharmaceutical products to other WTO Members, as in providing the legal framework for the application and issue of export compulsory licenses.'

Available Texts Main text(s) Main text(s) English Patents (Amendment) Ordinance 2007 (Ordinance No. 21 of 2007) (Chapter 514) PDF HTML
Legislation Amends (1 text(s)) Amends (1 text(s))
Patents Ordinance (Chapter 514) (amended up to E.R. 4 of 2020) (HK231)
 Is implemented by (1 text(s)) Is implemented by (1 text(s))
Patents (Amendment) Ordinance 2007 (Commencement) Notice (HK092)
WTO Document Reference
IP/N/1/HKG/P/1/Add.6
WIPO Lex No. HK091